tiprankstipranks
Emergent Biosolutions (EBS)
NYSE:EBS
US Market
EBS
Emergent Biosolutions
RESEARCH TOOLSreports
Want to see EBS full AI Analyst Report?

Emergent Biosolutions (EBS) Income Statement

1,361 Followers

Emergent Biosolutions Income Statement

Last quarter (Q4 2025), Emergent Biosolutions's total revenue was $148.70M, a decrease of -23.63% from the same quarter last year. In Q4, Emergent Biosolutions's net income was $-54.60M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 742.90M$ 1.04B$ 1.05B$ 1.12B$ 1.77B
Gross Profit
$ 350.60M$ 375.40M$ 360.00M$ 473.00M$ 793.20M
Operating Expenses
$ 240.40M$ 484.10M$ 1.09B$ 643.00M$ 451.80M
Depreciation and Amortization
$ 98.30M$ 105.60M$ 121.10M$ 125.00M$ 118.20M
EBITDA
$ 208.50M$ 53.40M$ -47.00M$ 15.70M$ 504.20M
Operating Income
$ 110.20M$ -108.70M$ -726.40M$ -170.00M$ 341.40M
Other Income/Expenses
$ -27.40M$ -34.20M$ -4.80M$ -49.00M$ -38.20M
Pretax Income
$ 82.80M$ -142.90M$ -731.20M$ -219.00M$ 303.20M
Net Income
$ 52.60M$ -190.60M$ -760.50M$ -211.60M$ 219.50M
Per Share Metrics
Basic EPS
$ 0.98$ -3.60$ -14.85$ -4.47$ 4.10
Diluted EPS
$ 0.93$ -3.60$ -14.85$ -4.47$ 4.06
Weighted Average Shares Outstanding
 53.50M 53.00M 51.20M 50.10M 53.50M
Weighted Average Shares Outstanding (Diluted)
 56.70M 53.00M 51.20M 50.10M 54.10M
Currency in USD

Emergent Biosolutions Earnings and Revenue History